Immunova to Acquire AlphaTON Subsidiary Iox Therapeutics
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Discover tailored wealth management advice for women to maximize their assets. Enhance your financial strategy now.
18,329 articlesImmunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
A new Federal Reserve chair is on the horizon, and markets are keen to know what it means for loans, mortgages, and i...
Navitas Semiconductor sits at the crossroads of faster charging and smarter energy use. This article maps possible pa...
A large holder trimmed a substantial stake in a biotech name while the stock advanced. This piece explains what inves...
A major biotech setback on Feb. 23 spooked investors and nudged major indices lower. This piece breaks down what happ...
Lucid Group delivered a stronger top line in Q4, but cash burn remains a key hurdle. Investors will parse the mix of ...
Income-focused investors are tuning in to Energy Transfer for a high-yield dividend and steady growth. This guide exp...
TSMC projects rapid AI chip revenue growth through 2029. This article breaks down what that means for investors in 20...
Bastion Asset Management just revealed a new stake in Parsons, signaling confidence in steady government spending on ...
Traders in March 2026 weigh the top platforms for options trading, balancing cost, tools, and risk controls. The fiel...
Power Solutions International plunged today amid a tech and energy-led market pullback. This analysis breaks down the...
GitLab delivered solid revenue growth but offered modest profitability guidance, triggering a sharp stock move. This ...